-
Bioreactors And Fermenters Market Size, Share And Growth Analysis For 2024-2033
13 May 2024 12:15 GMT
… fermenters market is due to increasing biotechnology investment. North … market is segmented into North America, South America, Asia-Pacific, Eastern Europe … and used to produce enzymes, antibiotics, … /company/the-business-research-company
Twitter: …
-
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
13 May 2024 11:30 GMT
… : AVTX), today announced business updates and financial results for … a clinical stage biotechnology company focused on the … market risks and uncertainties, including those caused by the war in Ukraine … . For media and investor inquiries Christopher Sullivan, …
-
Europe Meat Market Size, Share, Growth, Trends, Revenue, & Industry Report 2024-2032
13 May 2024 04:18 GMT
… towards ethically produced meats. Another significant … in Central and Eastern Europe. In these areas, … is a leading market research company that offers management … technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials …
-
Humacyte First Quarter 2024 Financial Results and Business Update
10 May 2024 11:00 GMT
… ), a clinical-stage biotechnology platform company developing universally implantable, … of wartime injuries in Ukraine under a humanitarian … affected by other economic, business, and/or … 6602
jallaire@lifesciadvisors.com
investors@humacyte.com Humacyte …
-
Carrageenan Market Set to Exceed USD 1349.97 Million by 2030, Driven by Rising demand for natural food thickeners
10 May 2024 07:19 GMT
… as Ukraine is a major producer of seaweed … market, expanding its portfolio of specialized plant nutrition and biostimulants.
• Birmingham Biotech … European markets, further advancing market reach and … the market research industry globally. Our company…
-
Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
09 May 2024 20:05 GMT
Seminal Phase 2b ASCEND trial top-line data expected in fourth quarter of 2024
Projected available cash to fund planned operations into early 2026 covering all studies through data Conference call scheduled for today at 4:30 p.m. Eastern Time BASKING RIDGE …
-
Artificial Intelligence (AI) In Clinical Trials Market Size, Share And Growth Analysis For 2024-2033
09 May 2024 14:30 GMT
… End-User: Pharmaceutical And Biotechnology Company, Contract Research Organizations, … market is segmented into North America, South America, Asia-Pacific, Eastern Europe … The Business Research Company:
Artificial Intelligence In Marketing Global Market Report …
-
Respiratory Syncytial Virus (RSV) Therapeutics Market to Grow at CAGR of 13 % through 2031 Owing to Rising Prevalence of RSV Infections and Potential Launch of Novel Therapies
09 May 2024 14:48 GMT
… presents a significant market opportunity. Currently … Therapeutics Market
The Russia-Ukraine war … investments in RSV therapeutics innovation and drug discovery. Pharmaceutical companies, biotechnology firms … company. We are a business that leads the industry …
-
Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
13 May 2024 12:00 GMT
… upcoming milestones and business activities. “The coming … is a clinical-stage biotechnology company discovering and developing … markets, the possibility of a recession and geopolitical conflict in Ukraine … by law. Investor Contact:
LHA Investor Relations
Jody …
-
Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
13 May 2024 12:00 GMT
OXFORD, United Kingdom, May 13, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic …